Announcement on Receiving the Shenzhen Stock Exchange "Advance Notice"
Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of the information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
The Company received the "Advance Notice" from the Shenzhen Stock Exchange on June 21, 2023, under document number [2023] No. 210. The specific content of the "Advance Notice" is as follows: